| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.90B | 13.66B | 12.87B | 11.86B | 10.66B | 9.11B |
| Gross Profit | 1.97B | 1.92B | 1.59B | 1.25B | 1.02B | 844.05M |
| EBITDA | 1.21B | 1.17B | 1.06B | 830.32M | 626.71M | 324.94M |
| Net Income | 238.35M | 151.56M | 132.31M | 188.08M | 686.31M | 547.98M |
Balance Sheet | ||||||
| Total Assets | 11.87B | 15.22B | 14.16B | 13.85B | 14.66B | 13.94B |
| Cash, Cash Equivalents and Short-Term Investments | 2.12B | 4.67B | 3.59B | 2.77B | 3.15B | 2.14B |
| Total Debt | 2.59B | 4.60B | 4.04B | 3.97B | 5.19B | 5.48B |
| Total Liabilities | 5.61B | 8.72B | 7.84B | 7.65B | 8.65B | 8.65B |
| Stockholders Equity | 6.25B | 6.50B | 6.32B | 6.20B | 6.01B | 5.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 498.35M | 769.61M | 886.82M | 1.26B | -576.71M |
| Operating Cash Flow | 0.00 | 929.47M | 976.09M | 1.18B | 2.28B | 1.60B |
| Investing Cash Flow | 0.00 | -413.81M | -224.42M | -347.61M | -1.02B | -2.33B |
| Financing Cash Flow | 0.00 | 562.40M | 70.50M | -1.21B | -241.01M | 1.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥15.88B | 8.49 | ― | 1.63% | 4.07% | 11.48% | |
78 Outperform | ¥17.96B | 13.55 | ― | 3.81% | 9.96% | 252.72% | |
75 Outperform | ¥44.43B | 28.75 | ― | 2.28% | 7.30% | 60.93% | |
71 Outperform | ¥33.14B | 14.97 | ― | 5.00% | ― | ― | |
64 Neutral | ¥10.59B | 20.28 | ― | 4.89% | 8.68% | 34.16% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥12.91B | 36.70 | ― | 0.84% | 8.44% | 17.98% |